Application of mesenchymal stem cells as a vehicle to deliver replication-competent adenovirus for treating malignant glioma (Q37183800)

18 August 2017

Application of mesenchymal stem cells as a vehicle to deliver replication-competent adenovirus for treating malignant glioma (English)

1 reference

18 August 2017

1 reference

mesenchymal stem cell

1 reference

Cui Hai

1

1 reference

18 August 2017

Yong-Min Jin

2

1 reference

18 August 2017

Wen-Biao Jin

3

1 reference

18 August 2017

Zhe-Zhu Han

4

1 reference

18 August 2017

Mei-Nv Cui

5

1 reference

18 August 2017

Xue-Zhe Piao

6

1 reference

18 August 2017

Xiong-Hu Shen

7

1 reference

18 August 2017

Song-Nan Zhang

8

1 reference

18 August 2017

Hong-Hua Sun

9

1 reference

18 August 2017

16 March 2012

1 reference

Chinese Journal of Cancer

18 August 2017

1 reference

18 August 2017

31

1 reference

18 August 2017

5

1 reference

18 August 2017

233-240

1 reference

https://scigraph.springernature.com/pub.10.1186/s13054-016-1344-z

18 August 2017

0 references

cites work

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777524

Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777524

Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmission

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777524

5/35 fiber-modified conditionally replicative adenovirus armed with p53 shows increased tumor-suppressing capacity to breast cancer cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777524

An adenoviral vector expressing human adenovirus 5 and 3 fiber proteins for targeting heterogeneous cell populations

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777524

Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777524

Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777524

Targeted delivery of adenoviral vectors by cytotoxic T cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777524

Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777524

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777524

Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777524

Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777524

Coxsackie and adenovirus receptor binding ablation reduces adenovirus liver tropism and toxicity

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777524

Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777524

Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777524

Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777524

3 September 2018

Mesenchymal stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777524

4 December 2018

Identifiers

DOI

10.5732/CJC.011.10367

1 reference

Dimensions Publication ID

18 August 2017

0 references

1 reference

18 August 2017

1 reference